iShares U.S. Pharmaceuticals ETF

People who switched from obesity injections to Novo‘s new Wegovy pill continued to lose weight after three months,…

Eli Lilly CEO Dave Ricks told CNBC on Monday that 700,000 new seniors have started GLP-1 treatments since…

Eli Lilly CEO Dave Ricks told CNBC on Monday that one-third of new GLP-1 pill patients are taking…

Novo Nordisk on Monday said it is rebranding its name to “Novo” and updating its corporate culture, as…

Novo Nordisk CEO Mike Doustdar on Wednesday defended the drugmaker’s decision to sue rival Eli Lilly over its…

The Eli Lilly and Novo Nordisk logos. Mike Blake | Tom Little | Reuters The diverging paths of…

Eli Lilly on Wednesday reported better-than-expected quarterly results and raised its full-year guidance as the company’s portfolio of…

Eli Lilly on Wednesday reported second-quarter earnings and revenue that blew past estimates and hiked its full-year sales outlook,…

Novo Nordisk CEO Maziar Mike Doustdar waits for the start of the pharmaceutical company’s annual general meeting in…

The Eli Lilly logo appears on the company’s office in San Diego, California, Nov. 21, 2025. Mike Blake…

Johnson & Johnson shares have showed signs of life ahead of earnings. For the stock to keep running,…

Exterior view of the Pfizer headquarters building on January 29, 2023 in New York City. View Press |…

Novo’s Wegovy pill improves weight loss after switch from injections